Cargando…

Characterization of the C6D7-RBD Human Monoclonal Antibody Specific to the SARS-CoV-2 S Protein Receptor-Binding Domain

The new coronavirus infection COVID-19 is an acute viral disease that affects primarily the upper respiratory tract. The etiological agent of COVID-19 is the SARS-CoV-2 RNA virus (Coronaviridae family, Betacoronavirus genus, Sarbecovirus subgenus). We have developed a high-affinity human monoclonal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romanenko, Ya. O., Silkina, M. V., Kartseva, A. S., Marin, M. A., Shkuratova, M. A., Makarova, M. A., Ryabko, A. K., Konyshkova, D. A., Zeninskaya, N. A., Khlyntseva, A. E., Shemyakin, I. G., Firstova, V. V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	A.I. Gordeyev 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154778/ https://www.ncbi.nlm.nih.gov/pubmed/37153507 http://dx.doi.org/10.32607/actanaturae.11849

Ejemplares similares

Mechanism of Action of Monoclonal Antibodies That Block the Activity of the Lethal Toxin of Bacillus Anthracis
por: Romanenko, Ya. O., et al.
Publicado: (2021)

Characterization of the adaptive immune response of donors receiving live anthrax vaccine
por: Firstova, Victoria V., et al.
Publicado: (2021)

Production and Characterization of Rat Monoclonal Antibodies against the PAL Antigen of Legionella spp.
por: Zeninskaya, N. A., et al.
Publicado: (2022)

Role of Structure-Based Changes due to Somatic Mutation in Highly Homologous DNA-Binding and DNA-Hydrolyzing Autoantibodies Exemplified by A23P Substitution in the VH Domain
por: Kozyr, A. V., et al.
Publicado: (2012)

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
por: Fan, Chengcheng, et al.
Publicado: (2022)

High Heterogeneity of Virus-Neutralizing and RBD-Binding Activities of COVID-19 Convalescent Sera
por: Astakhova, E. A., et al.
Publicado: (2022)

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
por: Rattanapisit, Kaewta, et al.
Publicado: (2020)

The Preferable Binding Pose of Canonical Butyrylcholinesterase Substrates Is Unproductive for Echothiophate
por: Zlobin, A. S., et al.
Publicado: (2018)

VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages
por: Kulemzin, Sergey V., et al.
Publicado: (2022)

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
por: Huang, Kuan-Ying A., et al.
Publicado: (2022)

Serum antibody levels to SARS-CoV-2 receptor-binding domain (RBD) in convalescent patients and vaccinated individuals of northern Nevada
por: Hau, Derrick, et al.
Publicado: (2023)

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
por: Scaria, Puthupparampil V., et al.
Publicado: (2022)

Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
por: Borgoyakova, Mariya B., et al.
Publicado: (2022)

DNA Double-Strand Breaks Coupled with PARP1 and HNRNPA2B1 Binding Sites Flank Coordinately Expressed Domains in Human Chromosomes
por: Tchurikov, Nickolai A., et al.
Publicado: (2013)

An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
por: Kostin, N. N., et al.
Publicado: (2022)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2017)

Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response
por: Lin, Ting-Wei, et al.
Publicado: (2022)

Natural IgG against S-Protein and RBD of SARS-CoV-2 Do Not Bind and Hydrolyze DNA and Are Not Autoimmune
por: Timofeeva, Anna M., et al.
Publicado: (2022)

Monoclonal Antibody HlyIIC‑15 to C-End Domain HlyII B. cereus Interacts with the Trombin Recognition Site
por: Zamyatina, A. V., et al.
Publicado: (2020)

Levels of SARS-COV-2 anti-spike protein receptor-binding domain (S-RBD) IgG in Indonesian-vaccinated healthcare workers: experimental research
por: Tambunan, Betty A., et al.
Publicado: (2023)

Receptor binding domain (RBD) antibodies contribute more to SARS-CoV-2 neutralization when target cells express high levels of ACE2
por: Farrell, Ariana Ghez, et al.
Publicado: (2022)

Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2
por: Farrell, Ariana Ghez, et al.
Publicado: (2022)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

Current Losses In Systems with the Electron Beam Energy Recovery in a Longitudinal Magnetic Field
por: Sharapa, A N, et al.
Publicado: (1994)

Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro
por: Omotuyi, Olaposi, et al.
Publicado: (2023)

The role of catalytic and regulatory domains of human PrimPol in DNA binding and synthesis
por: Boldinova, Elizaveta O, et al.
Publicado: (2023)

Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
por: Haycroft, Ebene R., et al.
Publicado: (2023)

CARF and WYL domains: ligand-binding regulators of prokaryotic defense systems
por: Makarova, Kira S., et al.
Publicado: (2014)

Next-Generation Techniques for Discovering Human Monoclonal Antibodies
por: Lushova, A. A., et al.
Publicado: (2017)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1
por: Law, John Lok Man, et al.
Publicado: (2021)

Potent anti-influenza H7 human monoclonal antibody induces separation of hemagglutinin receptor-binding head domains
por: Turner, Hannah L., et al.
Publicado: (2019)

Novel monoclonal antibodies targeting the microtubule-binding domain of human tau
por: Croft, Cara L., et al.
Publicado: (2018)

Impact spectropolarimetric sensing
por: Kazantsev, S A, et al.
Publicado: (1999)

Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement
por: Orengo, J. M., et al.
Publicado: (2018)

Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape
por: Zhao, Zhennan, et al.
Publicado: (2022)

Single‐dose immunisation with a multimerised SARS‐CoV‐2 receptor binding domain (RBD) induces an enhanced and protective response in mice
por: Salzer, Ralf, et al.
Publicado: (2021)

Technological Advancements in Monoclonal Antibodies
por: Santos-Neto, José F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5gfnke0u1u441gqma26ndd19v5